Autoantibodies against type I IFNs in patients with life-threatening COVID-19 P Bastard, LB Rosen, Q Zhang, E Michailidis, HH Hoffmann, Y Zhang, ... Science 370 (6515), eabd4585, 2020 | 2757 | 2020 |
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Q Zhang, P Bastard, Z Liu, J Le Pen, M Moncada-Velez, J Chen, M Ogishi, ... Science 370 (6515), eabd4570, 2020 | 2362 | 2020 |
A whole-genome association study of major determinants for host control of HIV-1 J Fellay, KV Shianna, D Ge, S Colombo, B Ledergerber, M Weale, ... science 317 (5840), 944-947, 2007 | 1539 | 2007 |
HIV evolution: CTL escape mutation and reversion after transmission AJ Leslie, KJ Pfafferott, P Chetty, R Draenert, MM Addo, M Feeney, ... Nature medicine 10 (3), 282-289, 2004 | 1064 | 2004 |
HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation RK Gupta, S Abdul-Jawad, LE McCoy, HP Mok, D Peppa, M Salgado, ... Nature 568 (7751), 244-248, 2019 | 768 | 2019 |
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects M J Buzón, M Massanella, JM Llibre, A Esteve, V Dahl, MC Puertas, ... Nature medicine 16 (4), 460-465, 2010 | 664 | 2010 |
Towards an HIV cure: a global scientific strategy Nature reviews Immunology 12 (8), 607-614, 2012 | 617 | 2012 |
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1 J Martinez-Picado, JG Prado, EE Fry, K Pfafferott, A Leslie, S Chetty, ... Journal of virology 80 (7), 3617-3623, 2006 | 552 | 2006 |
Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 542 | 2021 |
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1 J Martinez-Picado, AV Savara, L Sutton, RT D’Aquila Journal of virology 73 (5), 3744-3752, 1999 | 489 | 1999 |
Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009 | 488 | 2009 |
X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 389 | 2021 |
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection R Draenert, S Le Gall, KJ Pfafferott, AJ Leslie, P Chetty, C Brander, ... Journal of Experimental Medicine 199 (7), 905-915, 2004 | 383 | 2004 |
Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs C Katlama, SG Deeks, B Autran, J Martinez-Picado, J Van Lunzen, ... The Lancet 381 (9883), 2109-2117, 2013 | 376 | 2013 |
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells MJ Buzon, E Martin-Gayo, F Pereyra, Z Ouyang, H Sun, JZ Li, M Piovoso, ... Journal of virology 88 (17), 10056-10065, 2014 | 327 | 2014 |
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies FA Lempp, LB Soriaga, M Montiel-Ruiz, F Benigni, J Noack, YJ Park, ... Nature 598 (7880), 342-347, 2021 | 308 | 2021 |
Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway N Izquierdo-Useros, M Naranjo-Gómez, J Archer, SC Hatch, I Erkizia, ... Blood, The Journal of the American Society of Hematology 113 (12), 2732-2741, 2009 | 307 | 2009 |
Human genetic and immunological determinants of critical COVID-19 pneumonia Q Zhang, P Bastard, A Cobat, JL Casanova Nature 603 (7902), 587-598, 2022 | 287 | 2022 |
Antiretroviral resistance during successful therapy of HIV type 1 infection J Martinez-Picado, MP DePasquale, N Kartsonis, GJ Hanna, J Wong, ... Proceedings of the National Academy of Sciences 97 (20), 10948-10953, 2000 | 287 | 2000 |
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure V Miller, C Sabin, K Hertogs, S Bloor, J Martinez-Picado, R D'Aquila, ... Aids 14 (18), 2857-2867, 2000 | 282 | 2000 |